Primecap Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Primecap Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$802M	Sell	14,194,005 -355,309	-2%	-$20.7M	0.63%	44
2025 Q4	$865M	Sell	14,549,314 -679,973	-4%	-$37M	0.65%	41
2025 Q3	$825M	Sell	15,229,287 -542,886	-3%	-$31M	0.63%	45
2025 Q2	$867M	Sell	15,772,173 -2,001,108	-11%	-$118M	0.69%	44
2025 Q1	$1.26B	Sell	17,773,281 -415,890	-2%	-$28M	1.04%	29
2024 Q4	$1.2B	Sell	18,189,171 -678,264	-4%	-$45.4M	0.93%	35
2024 Q3	$1.33B	Buy	18,867,435 +77,350	+0.4%	+$6.47M	0.98%	30
2024 Q2	$1.55B	Buy	18,790,085 +76,190	+0.4%	+$6.34M	1.12%	23
2024 Q1	$1.63B	Buy	18,713,895 +299,521	+2%	+$26.8M	1.22%	19
2023 Q4	$1.78B	Buy	18,414,374 +7,835	+0%	+$693K	1.41%	18
2023 Q3	$1.63B	Buy	18,406,539 +22,920	+0.1%	+$2.04M	1.37%	18
2023 Q2	$1.59B	Buy	18,383,619 +140,190	+0.8%	+$13.2M	1.33%	19
2023 Q1	$1.77B	Buy	18,243,429 +662,570	+4%	+$68.7M	1.55%	17
2022 Q4	$1.82B	Sell	17,580,859 -44,646	-0.3%	-$4.19M	1.67%	15
2022 Q3	$1.49B	Sell	17,625,505 -52,980	-0.3%	-$4.72M	1.45%	18
2022 Q2	$1.47B	Sell	17,678,485 -100,985	-0.6%	-$8.04M	1.31%	22
2022 Q1	$1.37B	Sell	17,779,470 -25,310	-0.1%	-$2.12M	1.03%	27
2021 Q4	$1.57B	Sell	17,804,780 -132,550	-0.7%	-$10.9M	1.09%	26
2021 Q3	$1.39B	Sell	17,937,330 -15,736	-0.1%	-$1.24M	0.98%	27
2021 Q2	$1.5B	Sell	17,953,066 -204,728	-1%	-$16.2M	1.01%	27
2021 Q1	$1.37B	Buy	18,157,794 +9,833	+0.1%	+$803K	0.96%	31
2020 Q4	$1.59B	Sell	18,147,961 -43,580	-0.2%	-$3.46M	1.18%	24
2020 Q3	$1.38B	Buy	18,191,541 +307,570	+2%	+$31.1M	1.14%	22
2020 Q2	$2.21B	Buy	17,883,971 +74,204	+0.4%	+$7.37M	1.89%	13
2020 Q1	$1.5B	Buy	17,809,767 +1,480,447	+9%	+$128M	1.48%	18
2019 Q4	$1.38B	Buy	16,329,320 +1,167,246	+8%	+$88.2M	1%	29
2019 Q3	$1.02B	Buy	15,162,074 +878,321	+6%	+$67.7M	0.82%	38
2019 Q2	$1.22B	Buy	14,283,753 +92,880	+0.7%	+$7.95M	0.9%	34
2019 Q1	$1.26B	Buy	14,190,873 +5,700	+0%	+$528K	0.93%	33
2018 Q4	$1.21B	Sell	14,185,173 -23,312	-0.2%	-$2.22M	0.98%	30
2018 Q3	$1.38B	Sell	14,208,485 -32,304	-0.2%	-$3.22M	0.93%	33
2018 Q2	$1.34B	Buy	14,240,789 +474,250	+3%	+$41.5M	0.99%	30
2018 Q1	$1.12B	Buy	13,766,539 +3,521,244	+34%	+$302M	0.84%	37
2017 Q4	$914M	Buy	10,245,295 +606,651	+6%	+$52.8M	0.7%	42
2017 Q3	$897M	Buy	9,638,644 +328,420	+4%	+$29M	0.74%	38
2017 Q2	$846M	Buy	9,310,224 +597,956	+7%	+$54.4M	0.73%	42
2017 Q1	$765M	Buy	8,712,268 +826,320	+10%	+$73.5M	0.69%	45
2016 Q4	$653M	Buy	7,885,948 +777,819	+11%	+$66.9M	0.64%	46
2016 Q3	$658M	Sell	7,108,129 -211,190	-3%	-$19.9M	0.66%	46
2016 Q2	$569M	Sell	7,319,319 -31,050	-0.4%	-$2.64M	0.61%	48
2016 Q1	$606M	Buy	7,350,369 +19,680	+0.3%	+$1.6M	0.63%	50
2015 Q4	$768M	Sell	7,330,689 -34,350	-0.5%	-$3.59M	0.79%	39
2015 Q3	$776M	Sell	7,365,039 -627,710	-8%	-$83.8M	0.86%	31
2015 Q2	$1.09B	Sell	7,992,749 -32,259	-0.4%	-$4M	1.08%	23
2015 Q1	$1B	Buy	8,025,008 +8,490	+0.1%	+$900K	0.98%	27
2014 Q4	$725M	Sell	8,016,518 -27,400	-0.3%	-$2.28M	0.73%	39
2014 Q3	$580M	Sell	8,043,918 -20,301	-0.3%	-$1.33M	0.62%	44
2014 Q2	$502M	Sell	8,064,219 -99,500	-1%	-$6.01M	0.55%	50
2014 Q1	$557M	Buy	8,163,719 +603,590	+8%	+$44.5M	0.63%	44
2013 Q4	$532M	Sell	7,560,129 -46,800	-0.6%	-$3.18M	0.64%	38
2013 Q3	$549M	Sell	7,606,929 -77,400	-1%	-$5.14M	0.72%	36
2013 Q2	$429M	Buy	+7,684,329	New	+$479M	0.61%	46